SilverCrest Metals
SILV
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -293.15%-1.17M | -42.96%-1.62M | -1,533.09%-668.31K | -19,442.98%-1.32M | 62.36%-231.95K | 226.12%606.34K | -17,909.24%-1.13M | 85.75%-40.92K | 105.85%6.84K | -596.70%-616.22K |
Net income from continuing operations | 337.32%735.73K | 148.70%884.04K | 1,313.41%1.38M | 6.34%-351.16K | 119.70%163.75K | 37.40%-310.01K | -1.01%-1.82M | 66.16%-113.85K | 61.42%-374.93K | 51.15%-831.38K |
Operating gains losses | -98.94%11.81K | 1,059.00%1.81M | 1,185.72%409.35K | 209.57%225.72K | --63.55K | --1.11M | -43.75%156.22K | -90.02%31.84K | 161.06%72.91K | ---- |
Depreciation and amortization | 0.00%18.8K | 0.00%75.2K | -1.28%18.8K | 0.44%18.8K | 0.43%18.8K | 0.44%18.8K | 1.85%75.2K | 2.65%19.04K | -79.68%18.72K | 201.58%18.72K |
Other non cash items | -525.07%-1.9M | -157.36%-4M | -691.67%-2.45M | -127.16%-1.8M | -210.56%-198.74K | 214.74%446.46K | -2,817.29%-1.55M | 68.27%-309.31K | -296.64%-790.85K | -125.05%-63.99K |
Change In working capital | -692.04%-282.13K | 387.56%1.71M | 416.83%1.27M | 151.24%544.37K | -1,089.84%-67.43K | 66.32%-35.62K | 21.96%350.62K | -30.86%245.38K | 276.84%216.67K | -105.19%-5.67K |
-Change in receivables | 99.42%-299 | -89.95%26K | -38.14%187.7K | -123.84%-167.61K | 62.77%57.53K | -885.70%-51.62K | 21.05%258.64K | 3,170.91%303.41K | -141.39%-74.88K | 268.79%35.34K |
-Change in prepaid assets | 99.48%-652 | -346.15%-10.17K | -1,011.90%-10.81K | --0 | 9,539.85%125.32K | -9,691.00%-124.68K | -96.79%4.13K | -98.23%1.19K | 100.50%347 | -94.27%1.3K |
-Change in payables and accrued expense | -181.10%-174.91K | 8,340.53%881.16K | 5,322.30%855.91K | -83.04%8.84K | -1,987.72%-199.27K | 412.33%215.68K | -140.89%-10.69K | -92.19%15.79K | 122.23%52.12K | -108.89%-9.55K |
-Change in other working capital | -41.68%-106.26K | 724.48%812.53K | 413.85%235.39K | 194.10%703.14K | -55.66%-51K | -128.91%-75K | 294.75%98.55K | -198.10%-75K | --239.08K | ---32.76K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -293.15%-1.17M | -42.96%-1.62M | -1,533.09%-668.31K | -19,442.98%-1.32M | 62.36%-231.95K | 226.12%606.34K | -17,909.24%-1.13M | 85.75%-40.92K | 105.85%6.84K | -596.70%-616.22K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -2.03%-23.86K | -2.07%-93.71K | -86.20%-42.96K | 81.15%-3.98K | -1.06%-23.39K | 4.49%-23.39K | -4.14%-91.81K | -55.55%-23.07K | 79.33%-21.11K | -226.40%-23.14K |
Net other investing changes | -2.03%-23.86K | -2.07%-93.71K | -86.20%-42.96K | ---- | ---- | 4.49%-23.39K | -4.14%-91.81K | -55.55%-23.07K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -2.03%-23.86K | -2.07%-93.71K | -86.20%-42.96K | 81.15%-3.98K | -1.06%-23.39K | 4.49%-23.39K | -4.14%-91.81K | -55.55%-23.07K | 79.33%-21.11K | -226.40%-23.14K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 83.21%2M | 132.49%1.98M | 20K | 28.27%1.09M | 851.64K | 0 | ||||
Net common stock issuance | ---- | 83.21%2M | ---- | ---- | ---- | ---- | 31.16%1.09M | ---- | ---- | ---- |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | 83.21%2M | 132.49%1.98M | --20K | ---- | ---- | 28.27%1.09M | --851.64K | --0 | ---- |
Net cash flow | ||||||||||
Beginning cash position | 15.68%4.3M | -3.41%3.72M | -6.55%2.74M | 37.40%4.04M | 28.63%4.3M | -3.41%3.72M | 24.99%3.85M | -29.42%2.93M | -32.63%2.94M | -22.16%3.34M |
Current changes in cash | -355.37%-1.49M | 320.46%289.31K | 61.08%1.27M | -9,061.91%-1.31M | 36.06%-255.34K | 215.38%582.95K | -117.06%-131.23K | 360.75%787.65K | 93.49%-14.27K | -633.40%-399.36K |
End cash Position | -34.62%2.81M | 7.78%4.01M | 7.78%4.01M | -6.55%2.74M | 37.40%4.04M | 28.63%4.3M | -3.41%3.72M | -3.41%3.72M | -29.42%2.93M | -32.63%2.94M |
Free cash flow | -293.15%-1.17M | -42.96%-1.62M | -1,533.09%-668.31K | -2,443.05%-1.28M | 58.01%-278.73K | 226.12%606.34K | -17,909.24%-1.13M | 85.75%-40.92K | 146.56%54.47K | -635.09%-663.85K |
Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |